BACKGROUND: Short message service (SMS) surveys are a promising tool for understanding whether preexposure prophylaxis (PrEP) adherence aligns with risk for HIV acquisition-a concept known as prevention-effective adherence. METHODS: The Partners Demonstration Project was an open-label study of integrated PrEP and antiretroviral therapy (ART) delivery among high-risk HIV serodiscordant couples in East Africa. HIV-uninfected partners were offered PrEP until their HIV-infected partner had taken ART for ≥6 months. At 2 study sites, HIV-uninfected partners were offered enrollment into the Partners Mobile Adherence to PrEP (PMAP) substudy based on ongoing PrEP use, personal cell phone ownership, and ability to use SMS. SMS surveys asked about PrEP adherence and sexual activity in the previous 24 hours; these surveys were sent daily for the 7 days before and 7 days after routine study visits in the Partners Demonstration Project. RESULTS: The PMAP substudy enrolled 373 HIV-uninfected partners; 69% were men and mean age was 31 years. Participants completed 17,030 of 23,056 SMS surveys sent (74%) with a mean of 47 surveys per participant over 9.8 months of follow-up. While HIV-infected partner use of ART was <6 months, mean reported PrEP adherence was 92% on surveys concurrently reporting sex within the serodiscordant partnership, and 84% on surveys reporting no sex (P < 0.001). DISCUSSION: SMS surveys provided daily assessment of concurrent PrEP adherence and sexual behavior. Higher PrEP adherence was temporally associated with increased risk for HIV acquisition.
BACKGROUND: Short message service (SMS) surveys are a promising tool for understanding whether preexposure prophylaxis (PrEP) adherence aligns with risk for HIV acquisition-a concept known as prevention-effective adherence. METHODS: The Partners Demonstration Project was an open-label study of integrated PrEP and antiretroviral therapy (ART) delivery among high-risk HIV serodiscordant couples in East Africa. HIV-uninfected partners were offered PrEP until their HIV-infected partner had taken ART for ≥6 months. At 2 study sites, HIV-uninfected partners were offered enrollment into the Partners Mobile Adherence to PrEP (PMAP) substudy based on ongoing PrEP use, personal cell phone ownership, and ability to use SMS. SMS surveys asked about PrEP adherence and sexual activity in the previous 24 hours; these surveys were sent daily for the 7 days before and 7 days after routine study visits in the Partners Demonstration Project. RESULTS: The PMAP substudy enrolled 373 HIV-uninfected partners; 69% were men and mean age was 31 years. Participants completed 17,030 of 23,056 SMS surveys sent (74%) with a mean of 47 surveys per participant over 9.8 months of follow-up. While HIV-infected partner use of ART was <6 months, mean reported PrEP adherence was 92% on surveys concurrently reporting sex within the serodiscordant partnership, and 84% on surveys reporting no sex (P < 0.001). DISCUSSION: SMS surveys provided daily assessment of concurrent PrEP adherence and sexual behavior. Higher PrEP adherence was temporally associated with increased risk for HIV acquisition.
Authors: Richard T Lester; Paul Ritvo; Edward J Mills; Antony Kariri; Sarah Karanja; Michael H Chung; William Jack; James Habyarimana; Mohsen Sadatsafavi; Mehdi Najafzadeh; Carlo A Marra; Benson Estambale; Elizabeth Ngugi; T Blake Ball; Lehana Thabane; Lawrence J Gelmon; Joshua Kimani; Marta Ackers; Francis A Plummer Journal: Lancet Date: 2010-11-09 Impact factor: 79.321
Authors: Mackenzie L Cottrell; Kuo H Yang; Heather M A Prince; Craig Sykes; Nicole White; Stephanie Malone; Evan S Dellon; Ryan D Madanick; Nicholas J Shaheen; Michael G Hudgens; Jacob Wulff; Kristine B Patterson; Julie A E Nelson; Angela D M Kashuba Journal: J Infect Dis Date: 2016-02-24 Impact factor: 5.226
Authors: Julia L Marcus; Leo B Hurley; Charles Bradley Hare; Dong Phuong Nguyen; Tony Phengrasamy; Michael J Silverberg; Juliet E Stoltey; Jonathan E Volk Journal: J Acquir Immune Defic Syndr Date: 2016-12-15 Impact factor: 3.731
Authors: Michael C Thigpen; Poloko M Kebaabetswe; Lynn A Paxton; Dawn K Smith; Charles E Rose; Tebogo M Segolodi; Faith L Henderson; Sonal R Pathak; Fatma A Soud; Kata L Chillag; Rodreck Mutanhaurwa; Lovemore Ian Chirwa; Michael Kasonde; Daniel Abebe; Evans Buliva; Roman J Gvetadze; Sandra Johnson; Thom Sukalac; Vasavi T Thomas; Clyde Hart; Jeffrey A Johnson; C Kevin Malotte; Craig W Hendrix; John T Brooks Journal: N Engl J Med Date: 2012-07-11 Impact factor: 91.245
Authors: Jared M Baeten; Deborah Donnell; Patrick Ndase; Nelly R Mugo; James D Campbell; Jonathan Wangisi; Jordan W Tappero; Elizabeth A Bukusi; Craig R Cohen; Elly Katabira; Allan Ronald; Elioda Tumwesigye; Edwin Were; Kenneth H Fife; James Kiarie; Carey Farquhar; Grace John-Stewart; Aloysious Kakia; Josephine Odoyo; Akasiima Mucunguzi; Edith Nakku-Joloba; Rogers Twesigye; Kenneth Ngure; Cosmas Apaka; Harrison Tamooh; Fridah Gabona; Andrew Mujugira; Dana Panteleeff; Katherine K Thomas; Lara Kidoguchi; Meighan Krows; Jennifer Revall; Susan Morrison; Harald Haugen; Mira Emmanuel-Ogier; Lisa Ondrejcek; Robert W Coombs; Lisa Frenkel; Craig Hendrix; Namandjé N Bumpus; David Bangsberg; Jessica E Haberer; Wendy S Stevens; Jairam R Lingappa; Connie Celum Journal: N Engl J Med Date: 2012-07-11 Impact factor: 91.245
Authors: Craig W Hendrix; Adriana Andrade; Namandjé N Bumpus; Angela D Kashuba; Mark A Marzinke; Ayana Moore; Peter L Anderson; Lane R Bushman; Edward J Fuchs; Ilene Wiggins; Christine Radebaugh; Heather A Prince; Rahul P Bakshi; Ruili Wang; Paul Richardson; Eugenie Shieh; Laura McKinstry; Xin Li; Deborah Donnell; Vanessa Elharrar; Kenneth H Mayer; Kristine B Patterson Journal: AIDS Res Hum Retroviruses Date: 2015-10-15 Impact factor: 2.205
Authors: Ariane van der Straten; Elizabeth T Montgomery; Petina Musara; Juliane Etima; Sarita Naidoo; Nicole Laborde; Miriam Hartmann; Lisa Levy; Thola Bennie; Helen Cheng; Jeanna Piper; Cynthia I Grossman; Jeanne Marrazzo; Barbara Mensch Journal: AIDS Date: 2015-10-23 Impact factor: 4.177
Authors: Deborah Donnell; Jared M Baeten; Namandjé N Bumpus; Justin Brantley; David R Bangsberg; Jessica E Haberer; Andrew Mujugira; Nelly Mugo; Patrick Ndase; Craig Hendrix; Connie Celum Journal: J Acquir Immune Defic Syndr Date: 2014-07-01 Impact factor: 3.731
Authors: Amy L Corneli; Kevin McKenna; Jennifer Headley; Khatija Ahmed; Jacob Odhiambo; Joseph Skhosana; Meng Wang; Kawango Agot Journal: J Int AIDS Soc Date: 2014-09-08 Impact factor: 5.396
Authors: Timothy R Muwonge; Kenneth Ngure; Elly Katabira; Nelly Mugo; Grace Kimemia; Bridget Frances O'Rourke Burns; Nicholas Musinguzi; Felix Bambia; Jared M Baeten; Renee Heffron; Jessica E Haberer Journal: AIDS Behav Date: 2019-05
Authors: Valentine Wanga; Jared M Baeten; Elizabeth A Bukusi; Nelly R Mugo; Stephen Asiimwe; Kenneth Ngure; Andrew Mujugira; Timothy Muwonge; Josephine B Odoyo; Jessica E Haberer; Connie Celum; Renee Heffron Journal: AIDS Behav Date: 2020-07
Authors: Surulivelrajan Mallayasamy; Ayyappa Chaturvedula; Michael J Fossler; Mark Sale; Vineet Goti; Namandje N Bumpus; Mark A Marzinke; Craig W Hendrix; Jessica E Haberer Journal: Antimicrob Agents Chemother Date: 2019-07-25 Impact factor: 5.191
Authors: Jennifer Velloza; Kenneth Ngure; Catherine Kiptinness; Justice Quame-Amaglo; Nicholas Thuo; Kristin Dew; Mary Kimani; Stephen Gakuo; Jennifer A Unger; Beth Kolko; Jared M Baeten; Connie Celum; Nelly Mugo; Renee Heffron Journal: Mhealth Date: 2019-02-14
Authors: Renee Heffron; Kenneth Ngure; Josephine Odoyo; Nulu Bulya; Edna Tindimwebwa; Ting Hong; Lara Kidoguchi; Deborah Donnell; Nelly R Mugo; Elizabeth A Bukusi; Elly Katabira; Stephen Asiimwe; Jennifer Morton; Susan Morrison; Harald Haugen; Andrew Mujugira; Jessica E Haberer; Norma C Ware; Monique A Wyatt; Mark A Marzinke; Lisa M Frenkel; Connie Celum; Jared M Baeten Journal: Gates Open Res Date: 2018-01-30
Authors: Katrina F Ortblad; John E Kearney; Kenneth Mugwanya; Elizabeth M Irungu; Jessica E Haberer; Ruanne V Barnabas; Deborah Donnell; Nelly Rwamba Mugo; Jared M Baeten; Kenneth Ngure Journal: Trials Date: 2019-07-04 Impact factor: 2.279